Allogenic human umbilical cord derived mesenchymal stem cell ( Quansheng Biotechnology)

人脐带间充质干细胞（泉生生物）

Report date: 2024/02/19 17:04:37

Base Information

Drug NameAllogenic human umbilical cord derived mesenchymal stem cell ( Quansheng Biotechnology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsBurnsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic Obstructive +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAsia Stem Cell Regenerative Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAsia Stem Cell Regenerative Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBurnsRespiratory Distress Syndrome, AdultPulmonary Disease, Chronic Obstructive +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A